Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' ...

27, 2024 – The maker of the weight loss drug Zepbound is offering the drug at a reduced price for people willing ... week supply in prefilled pens. The announcement described the vials the ...

The Indiana-based drugmaker’s much-publicized announcement was welcomed ... LLY applied the price cut only to 2.5 mg and 5.0 mg doses of Zepbound available on its direct-to-consumer platform ...

Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound ... The move to only cut the prices of the lowest doses, she added ...

Eli Lilly (NYSE:LLY) shares edged around 0.7% lower Tuesday as the company announced a price cut for its obesity drug Zepbound ... They believe the announcement also "likely further bolsters ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

As Europe’s biggest pharmaceutical company, Novo Nordisk made this move shortly after U.S. rival Eli Lilly cut prices on its ...

The new weight-loss option will cut what ... year at current prices if every adult dealing with obesity took the drugs. Competition that drives down the cost of Wegovy and Zepbound could help ...

On Tuesday, Eli Lilly announced that it would start selling low doses of its weight-loss drug Zepbound in vials, too — at a far lower price than ... Lilly’s announcement also presents a ...